Misplaced Pages

AIDS Vaccine 200: Difference between revisions

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Browse history interactively← Previous editContent deleted Content addedVisualWikitext
Revision as of 07:24, 22 April 2009 editBleakcomb (talk | contribs)Extended confirmed users, Pending changes reviewers7,336 editsm Hectares for lakes too!← Previous edit Latest revision as of 12:41, 30 August 2024 edit undoCitation bot (talk | contribs)Bots5,408,094 edits Added title. Changed bare reference to CS1/2. | Use this bot. Report bugs. | Suggested by Grimes2 | #UCB_webform 598/1891 
(96 intermediate revisions by 31 users not shown)
Line 1: Line 1:
{{Short description|Annual charity bicycle ride in Georgia, US}}
]<br> ]


is a challenging, {{convert|200|mi|km|adj=on}}, charity bike ride through the rolling hills of northeast ]. The ride raises vital funds for research at the ], one of the world's leading vaccine research centers working to find an ]. '''AIDS Vaccine 200''' (AV 200) is a charity bike ride through the scenic ] countryside. The ride raises awareness and vital funds for HIV/AIDS vaccine research having donated to date over $3.5 million to the ], one of the world's leading vaccine research centers working to find an ], and other beneficiaries.<ref>{{cite web | url=https://actioncyclingatl.org/press-release-may-9-2022/ | title=Press Release - May 9, 2022 }}</ref>


==The Ride== ==The ride==
The ride takes place in May on the weekend before ] each year. Up to 100 cyclists and an army of volunteers complete the ride each year. The ride begins on the campus of ] in ] and passes through several small, ] towns until cyclists arrive at the Rock Eagle 4-H Center located north of Eatonton, Georgia in the ]. Cyclists and volunteers lodge Saturday night at cabins located next to Rock Eagle's {{convert|110|acre|ha|adj=on}} lake. Cyclists choose several different mileage options and can customize the length of the ride to their ability levels. The full ride entails back-to-back, century rides, {{convert|100|mi|km}} each day for a total of {{convert|200|mi|km}}. Cyclists may also choose a shorter {{convert|80|mi|km|adj=on}} route for a total of {{convert|160|mi|km}}. Another option is for cyclists to form relay squads of up to 5 riders. The squad then divides the {{convert|100|mi|km|adj=on}} distance each day into relay segments as long as each cyclist wishes to ride. The ride follows country roads across rural areas and rolling hills as riders pass through several small, ] towns including Stone Mountain, Walnut Grove, Social Circle, and Madison. The 2-day ride takes place in May each year. More than 150 cyclists and an army of volunteers complete the ride each year. The ride begins on the campus of ] in ] and passes through several small, ] towns until cyclists arrive at the Rock Eagle 4-H Center located north of Eatonton, Georgia in the ]. Cyclists and volunteers lodge Saturday night in cabins located alongside the edge of Rock Eagle's {{convert|110|acre|ha|adj=on}} lake. Cyclists choose several different mileage options and can customize the length of the ride to their ability levels. The full ride entails back-to-back ]s, {{convert|100|mi|km}} each day for a total of {{convert|200|mi|km}}. Cyclists may also choose a shorter {{convert|80|mi|km|adj=on}} route for a total of {{convert|160|mi|km}}. A third option is for cyclists to form relay squads of up to 5 riders. The squad then divides the {{convert|100|mi|km|adj=on}} distance each day into relay segments as long as each cyclist wishes to ride. The ride follows country roads across rural areas and rolling hills as riders pass through several small, ] towns including Stone Mountain, Jersey, Social Circle, and Godfrey.


==History== ==History==
Action Cycling Atlanta was formed in 2002 by a group of cyclists who had participated in the 2001 European AIDS Vaccine Ride, one of the last ] produced by Pallotta Teamworks. This group of volunteers were dismayed at the cost overruns of the European ride.<ref></ref><ref></ref><ref></ref> Also, the end of Pallotta Teamworks created a fundraising vacuum for the beneficiaries supported by the AIDSRides. Action Cycling Atlanta was incorporated as a 501c3 charitable organization and chose to continue fundraising for AIDS vaccine research at the ]. The ride existed as the Action Cycling 200 for its first 6 years and has donated over $400,000 for AIDS vaccine research at ]. Written into the bylaws of Action Cycling is its commitment to adhere to the standards set forth by the Better Business Bureau's ] and to minimizing event expenses returning as much of the funds raised directly to the charitable cause. To date, 100% of the money raised by ride participants has been donated to the beneficiary. Action Cycling is able to do this by underwriting the cost of the event through registration fees and generous event sponsors. The ride originally traveled from the ] in Decatur, GA to Athens, GA. To accommodate more riders, in 2007, ride organizers changed the route to begin and end on the Emory University campus with a Saturday night stay at Rock Eagle near Eatonton, GA. In 2009, the name of the ride was changed to the AIDS Vaccine 200 to better communicate the purpose of the ride. Action Cycling Atlanta, Inc. (ACA) was formed in 2003 by a group of cyclists who had participated in the 2002 European AIDS Vaccine Ride, one of the last ] produced by Pallotta Teamworks. The group was dismayed at cost overruns of the European ride.<ref></ref><ref> {{webarchive |url=https://web.archive.org/web/20110525203738/http://www.aegis.com/news/wb/2002/WB020702.html |date=May 25, 2011 }}</ref><ref></ref> Also, the end of Pallotta Teamworks created a fundraising vacuum for the beneficiaries receiving proceeds from the rides produced by Pallotta. Action Cycling Atlanta was incorporated as a 501c3 charitable organization and chose to continue fundraising for AIDS vaccine research at the ], located in Atlanta, GA and a former beneficiary of the Pallotta events. The ride existed as the Action Cycling 200 for its first 6 years. Fundraising results of $175,000 in 2009 pushed the amount that ACA had donated to over $575,000. The majority of these funds ($557,000) has gone towards AIDS vaccine research at ]. The ride also occasionally donates a portion of ride proceeds to related ]s. Written into the bylaws of Action Cycling Atlanta is its commitment to adhere to the standards set forth by the Better Business Bureau's ] and to minimizing event expenses returning as much of the funds raised directly to the charitable cause. To date, 100% of the money raised by ride participants has been donated to the beneficiary. Action Cycling Atlanta is able to do this by underwriting the cost of the event through registration fees and generous event sponsors. The ride originally traveled from the Hope Clinic in Decatur, GA to Athens, GA. To accommodate more riders, in 2007, ride organizers changed the route to begin and end on the Emory University campus with a Saturday night stay at Rock Eagle near Eatonton, GA. In 2009, the name of the ride was changed to the AIDS Vaccine 200 to communicate more clearly the purpose of the ride.<ref name="AIDS Vaccine 200 History"></ref>


==Fundraising results==
==The Beneficiary==
The ride has been able to provide increased funding year over year due to the diligence of volunteers. One of the reasons Action Cycling Atlanta is so fiscally effective is that no part of the money raised through sponsorships or fundraising donations is spent on salaries of any kind. To date (August 2017), Action Cycling Atlanta, through its Action Cycling 200 and AIDS Vaccine 200 rides has donated a total of $2,781,090 for AIDS vaccine research and AIDS-related services.
The ] works to improve human health by conducting fundamental and clinical research that leads to the development of effective vaccines against diseases of global importance. Developing a vaccine to halt the AIDS epidemic is a key part of the mission of the ], and much of the research at the EVC relates to this effort. Scientists specializing in basic immunology strive to elucidate the fundamental workings of the immune system and how it responds to infection. Other investigators examine the interaction between HIV and the immune cells it attacks in order to identify ways to prevent or interrupt the process by which the virus destroys the immune system.


<!-- Deleted image removed: ] -->
Researchers translate these findings into new AIDS vaccine strategies, which are tested rigorously in preclinical studies for safety and efficacy before being considered for human clinical trials. The ] of the Emory Vaccine Center, a freestanding clinic located in downtown Decatur, Georgia, conducts vaccine clinical trials and related research studies involving human volunteers. Thus, the EVC’s AIDS vaccine program spans the entire research process, from basic science to translational research to preclinical and clinical trials.


'''Fundraising Results by Year'''
The EVC is the only university-based vaccine research center in the U.S. to have an AIDS vaccine candidate in clinical trials. Created and developed by EVC scientist Harriet Robinson, Ph.D., and her colleagues at the Centers for Disease Control and Prevention and the National Institute of Allergy and Infectious Diseases, this vaccine candidate began phase 2 human trials in February 2009. The trial, designated HVTN 205, is being conducted by the ].<ref></ref> Dr. Robinson joined GeoVax, a company which she co-founded, to be able to steward her vaccine candidate through the phase 2 clinical trials now underway. "It's important for me to be at GeoVax full time to work with our excellent team in this important effort," said Dr. Robinson. "It is my conviction that our AIDS vaccine is a prime candidate to be safe and effective in preventing AIDS."<ref></ref>
{| class="wikitable" border="1" style="text-align:center;1px"

! Year !! Total !! Emory Vaccine Center !!AID Atlanta !! AIDS Athens !! Jerusalem House !! Positive Impact
==The Importance of Unrestricted Funds for AIDS Vaccine Research==
|-
Large donations in the form of government or foundation grants fail to cover many essential expenses. ] relies upon individual or unrestricted donations to fund the exploration of new ideas before larger grants become available. On average, each private funding dollar is leveraged into 17 additional research dollars in the form of prestigious federal grants. ] credits Action Cycling as one source of unrestricted funds used to begin initial research by Harriet Robinson. Data from those initial tests were used to qualify for large grants to continue funding the research that has resulted in an AIDS vaccine candidate moving into Phase II human trials.<ref></ref>
| 2003 || $49,365 || $49,365 || - || - || - || -
|-
| 2004 || $59,075 || $59,075 || - || - || - || -
|-
| 2005 || $52,125 || $37,000 || - || $15,125|| - || -
|-
| 2006 || $79,975 || $74,975 || - || $5,000 || - || -
|-
| 2007 || $75,500 || $75,500 || - || - || - || -
|-
| 2008 || $106,000 || $106,000 || - || - || - || -
|-
| 2009 || $175,000 || $175,000 || - || - || - || -
|-
| 2010 || $198,200 || $190,000 || - || - || $6,200 || $2,000
|-
|2011 || $233,700 || $205,700 || - || - || $25,000 || $3,000
|-
|2012 || $297,500 || $260,000 || - || - || $35,000 || $2,500
|-
|2013 || $304,000 || $255,000 || - || - || $37,000 || $12,000
|-
|2014 || $223,000 || $163,100 || $17,500 || - || $27,000 || $15,400
|-
|2015 || $249,150 || $200,000 || - || - || $32,850 || $16,300
|-
|2016
|$320,000
|$260,300
| -
| -
|$57,000
|$2,700
|-
|2017
|$358,500
|$305,600
| -
| -
|$47,100
|$5,800
|-
| '''Total''' || '''$2,781,090''' || '''$2,416,615''' || '''$17,500''' || '''$20,125''' ||'''$267,150'''|| '''$59,700'''
|}


⚫ ==See also==
⚫ * ]
* ]
⚫ * ]
* ]
== References == == References ==
⚫ <references />

⚫ <references/>


==External links== ==External links==
* *
*
*
*
*
*
*

⚫ ==See also==
⚫ *]
*]
⚫ *]



] ]
] ]

Latest revision as of 12:41, 30 August 2024

Annual charity bicycle ride in Georgia, US
AIDS Vaccine 200 logo

AIDS Vaccine 200 (AV 200) is a charity bike ride through the scenic Georgia countryside. The ride raises awareness and vital funds for HIV/AIDS vaccine research having donated to date over $3.5 million to the Emory Vaccine Center, one of the world's leading vaccine research centers working to find an HIV vaccine, and other beneficiaries.

The ride

The 2-day ride takes place in May each year. More than 150 cyclists and an army of volunteers complete the ride each year. The ride begins on the campus of Emory University in Atlanta and passes through several small, Georgia towns until cyclists arrive at the Rock Eagle 4-H Center located north of Eatonton, Georgia in the Oconee National Forest. Cyclists and volunteers lodge Saturday night in cabins located alongside the edge of Rock Eagle's 110-acre (45 ha) lake. Cyclists choose several different mileage options and can customize the length of the ride to their ability levels. The full ride entails back-to-back century rides, 100 miles (160 km) each day for a total of 200 miles (320 km). Cyclists may also choose a shorter 80-mile (130 km) route for a total of 160 miles (260 km). A third option is for cyclists to form relay squads of up to 5 riders. The squad then divides the 100-mile (160 km) distance each day into relay segments as long as each cyclist wishes to ride. The ride follows country roads across rural areas and rolling hills as riders pass through several small, Georgia towns including Stone Mountain, Jersey, Social Circle, and Godfrey.

History

Action Cycling Atlanta, Inc. (ACA) was formed in 2003 by a group of cyclists who had participated in the 2002 European AIDS Vaccine Ride, one of the last AIDSRides produced by Pallotta Teamworks. The group was dismayed at cost overruns of the European ride. Also, the end of Pallotta Teamworks created a fundraising vacuum for the beneficiaries receiving proceeds from the rides produced by Pallotta. Action Cycling Atlanta was incorporated as a 501c3 charitable organization and chose to continue fundraising for AIDS vaccine research at the Emory Vaccine Center, located in Atlanta, GA and a former beneficiary of the Pallotta events. The ride existed as the Action Cycling 200 for its first 6 years. Fundraising results of $175,000 in 2009 pushed the amount that ACA had donated to over $575,000. The majority of these funds ($557,000) has gone towards AIDS vaccine research at Emory Vaccine Center. The ride also occasionally donates a portion of ride proceeds to related AIDS service organizations. Written into the bylaws of Action Cycling Atlanta is its commitment to adhere to the standards set forth by the Better Business Bureau's Wise Giving Alliance and to minimizing event expenses returning as much of the funds raised directly to the charitable cause. To date, 100% of the money raised by ride participants has been donated to the beneficiary. Action Cycling Atlanta is able to do this by underwriting the cost of the event through registration fees and generous event sponsors. The ride originally traveled from the Hope Clinic in Decatur, GA to Athens, GA. To accommodate more riders, in 2007, ride organizers changed the route to begin and end on the Emory University campus with a Saturday night stay at Rock Eagle near Eatonton, GA. In 2009, the name of the ride was changed to the AIDS Vaccine 200 to communicate more clearly the purpose of the ride.

Fundraising results

The ride has been able to provide increased funding year over year due to the diligence of volunteers. One of the reasons Action Cycling Atlanta is so fiscally effective is that no part of the money raised through sponsorships or fundraising donations is spent on salaries of any kind. To date (August 2017), Action Cycling Atlanta, through its Action Cycling 200 and AIDS Vaccine 200 rides has donated a total of $2,781,090 for AIDS vaccine research and AIDS-related services.


Fundraising Results by Year

Year Total Emory Vaccine Center AID Atlanta AIDS Athens Jerusalem House Positive Impact
2003 $49,365 $49,365 - - - -
2004 $59,075 $59,075 - - - -
2005 $52,125 $37,000 - $15,125 - -
2006 $79,975 $74,975 - $5,000 - -
2007 $75,500 $75,500 - - - -
2008 $106,000 $106,000 - - - -
2009 $175,000 $175,000 - - - -
2010 $198,200 $190,000 - - $6,200 $2,000
2011 $233,700 $205,700 - - $25,000 $3,000
2012 $297,500 $260,000 - - $35,000 $2,500
2013 $304,000 $255,000 - - $37,000 $12,000
2014 $223,000 $163,100 $17,500 - $27,000 $15,400
2015 $249,150 $200,000 - - $32,850 $16,300
2016 $320,000 $260,300 - - $57,000 $2,700
2017 $358,500 $305,600 - - $47,100 $5,800
Total $2,781,090 $2,416,615 $17,500 $20,125 $267,150 $59,700

See also

References

  1. "Press Release - May 9, 2022".
  2. The big wheel / Critics don't faze Dan Pallotta, who has helped raise big bucks for AIDS research - and his company
  3. Pallotta announces end to AIDS Vaccine Rides: Even with production fee forfeited, beneficiaries to receive less than 10 percent Archived May 25, 2011, at the Wayback Machine
  4. Pallotta TeamWorks Record of Impact: Detailed Financial Disclosure
  5. AIDS Vaccine 200 Website - History

External links

Categories: